Findex Inc

Findex Inc maintains a strong liquidity position, with a current ratio of 3.65 and cash and equivalents of ¥1.68 billion, representing 24.7% of total assets. The company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. The price-to-book ratio of 3.6 and price-to-tangible-book ratio of 3.6 suggest a premium valuation relative to its book value. Profitability metrics show a return on equity (ROE) of 23.1% and return on assets (ROA) of 18.5%, both exceeding the typical thresholds for the healthcare technology industry. The operating margin of 28.4% (calculated from operating income of ¥1.73 billion on revenue of ¥6.11 billion) is robust, indicating efficient cost management and strong pricing power. The company operates in two segments: System Development and Health Tech. The System Development segment focuses on medical system development and office systems, while the Health Tech segment includes AI and data science in healthcare. Revenue concentration data is not provided, but the dual-segment model suggests diversification within the healthcare technology space. Findex Inc's revenue for the latest period was ¥6.11 billion, with analysts estimating ¥6.25 billion for the next period, indicating a potential 2.2% year-over-year growth. The company's free cash flow of ¥881 million and operating cash flow of ¥1.65 billion support its growth initiatives and financial flexibility. Risk factors for Findex Inc are low, with no immediate liquidity or dilution flags detected. The company has no long-term debt and a low dilution risk, as shares outstanding remain unchanged between basic and diluted measures. No recent filings or transcripts indicate significant near-term risk events. Recent financial performance aligns with analyst expectations, with actual EPS of ¥50.07 versus a mean estimate of ¥54.10, and actual revenue of ¥6.11 billion versus a mean estimate of ¥6.25 billion. The company's performance suggests stable operations and alignment with market expectations.